The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Prior to appointment as a Consultant Clinical Oncologist at the Northern Centre for Cancer Care, Dr Muhammad Shahid Iqbal completed Clinical Oncology training in the north east, and he is also a core member of the Stereotactic Body Radiotherapy (SBRT) team.
His areas of sub-specialisation are the non-surgical management of thoracic and head & neck malignancies involving both radiotherapy and chemotherapy treatments.
Dr Muhammad Shahid Iqbal has authored a number of publications, and maintains a keen interest in clinical research and trials.
He was a member of The Royal College of Radiologists final FRCR Examination Board for part A (SBA) from 2013 to 2017. Currently Dr Muhammad Shahid Iqbal is a member of The Royal College of Radiologists Clinical Oncology Professional Learning and Development Committee.
General Medical Council
The Royal College of Radiologists
European Society of Radiotherapy and Oncology
Dr Bart Kurec does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Dr Bart Kurec does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Dr Bart Kurec does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.